Head Office Oxford
CEO Dr Holly Reeve
CSO Dr Sarah Cleary
CGF Board Rep Susannah McClintock
HydRegen is pioneering the production of bio-based catalysts that enable cleaner, safer and more energy-efficient manufacturing processes for the global pharmaceutical and chemicals industries. Their innovative biotechnology aims to deliver huge CO₂ savings and operating costs by replacing toxic metal catalysts with environmentally and economically friendly bio-based alternatives.
Picture credits: www.charlieflounders.com
